President’s letter
2020 Metrics
Cycle of Translation
Visionary Gifts
Discovery to Clinic
Innovative Education
Translational Luminaries
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
result
Outcomes Research
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
COVID-19 Studies
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Science in Service
of
Medicineresult
President's letter
2020 Metrics
Cycle of Translation
Visionary Gifts of Hope
Introduction
The Ann Kimbell and John W. Johnson Center for Cellular Therapeutics
The Fondren Food & Health Alliance and The Fondren Inflammation Center
Cockrell Center for Advanced Therapeutics
Paula and Joseph C. “Rusty” Walter III Translational Research Initiative
Jerold B. Katz Academy of Translational Research
From Discovery to Clinic
Introduction
Restorative Medicine
Houston Methodist and Rice University Launch Center for Translational Neural Prosthetics and Interfaces
Non-invasive Spinal Stimulation Enables Paralyzed People to Stand Unassisted
Dissolvable Implants Enhance the Body’s Ability to Heal Broken Bones
Cell Encapsulation May Hold the Key to Preventing Cell Transplant Rejection
Revolutionizing the Future of Complex Valve Disease Management
Precision Medicine
CPRIT Funding to Drive New Discoveries in Cancer Therapeutics
An Innovative New Tool to Enable Drug Discovery and Personalized Medicine
Devising a Novel Combination Treatment for Aggressive Double-hit Lymphoma
Expanding the RNAcore to Encompass the Entire Cycle of a Cure
Siemens Healthineers and Houston Methodist Imaging Innovation Hub Empowers Researchers to Push the Boundaries
Novel Monoclonal Antibody Treatment Halts Tumor Growth in Deadly Ovarian and Pancreatic Cancers
Houston Methodist Institute for Technology, Innovation & Education (MITIESM)
Surgical Technology Developed in MITIE Gains FDA Approval
Pushing the Frontier of the Robotics Revolution
Can Devices Provide A New Treatment Option for Glioblastoma?
Houston Methodist Hospital’s new Paula and Joseph C. “Rusty” Walter III Tower offers the Most advanced treatments and innovations available
Neuroimaging Offers New Insights into Neurodegeneration
Translational Luminaries
Discovery to Clinic
Outcomes Research
Mobile App for Breast Cancer Survivors Promote Healthy Lifestyle Choices and Weight Loss
Mobile App for Breast Cancer Survivors Promote Healthy Lifestyle Choices and Weight Loss
Share this story
Breast cancer treatment often leads to unintentional weight gain, which is concerning because obesity is associated with an increased risk of breast cancer recurrence and a higher rate of hospital readmissions.
Renee Stubbins, PhD
Stephen T.C. Wong, PhD
While weight management tools are among the most frequently accessed health apps, most are not tailored to the specific needs of cancer survivors. Stephen T. C. Wong, PhD, John S. Dunn, Sr. Presidential Distinguished Chair in Biomedical Engineering and his informatics development team designed a mobile app called The Methodist Hospital Cancer Health Application or MOCHA to be an interactive resource that helps post-treatment cancer survivors to make healthy lifestyle choices including weight loss.
Maintaining a healthy weight is difficult enough for the average person, let alone for breast cancer survivors. With MOCHA, we can track multiple patients at once, identify those who need additional support or intervention and communicate with them via real-time messaging to help them stay motivated. This is a tremendous improvement from the typical 6-month clinic visit schedule for breast cancer survivors, between which patients can lose motivation and experience weight gain.”
Renee Stubbins, PhD
Houston Methodist
A four-week pilot study of the MOCHA app revealed that 56 percent of enrolled patients lost an average of 3.5 pounds and that frequency of app use was positively linked with weight loss. The complete results are available in the journal, JCO Clinical Cancer Informatics. The next phase of this study will involve 12 weeks of intervention and one year of follow-up. While the app is currently accessible only to study participants, the goal is to broaden its use and focus on changing long-term behaviors to reduce health issues most common in cancer survivors.
More from Discovery to Clinic